
National Research Corporation NRC
$ 19.04
-0.03%
Quarterly report 2026-Q1
added 05-06-2026
National Research Corporation EV/EBITDA Ratio 2011-2026 | NRC
Annual EV/EBITDA Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 | 10.5 | 23.4 | 25.1 | 21 | 22.9 | 35.8 | 26.7 | 22.3 | 10.9 | 10.8 | 9.46 | 12.7 | - | - | 2.35 | -0.143 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.8 | -0.143 | 16.5 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 17.71 | 0.23 % | $ 545 M | ||
|
Guardant Health
GH
|
-38.2 | $ 127.1 | 6.05 % | $ 15.9 B | ||
|
Agilent Technologies
A
|
27.4 | $ 115.84 | 0.68 % | $ 35.2 B | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
-32.4 | $ 134.06 | -0.15 % | $ 6.27 B | ||
|
Illumina
ILMN
|
70.5 | $ 150.12 | 3.37 % | $ 23.9 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 7.51 | -17.59 % | $ 9.99 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 21.12 | 7.26 % | $ 612 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 22.16 | 2.88 % | $ 1.18 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
14.8 | $ 117.02 | 2.78 % | $ 9.65 B | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 99.59 | -0.47 % | $ 6.72 B | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 094.73 | -0.6 % | $ 22.6 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 9.52 | 2.7 % | $ 1.22 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Natera
NTRA
|
-19.5 | $ 204.64 | 1.86 % | $ 20.1 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 162.76 | 3.97 % | $ 8.07 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 430.1 | 0.23 % | $ 12.4 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 3.93 | 1.95 % | $ 364 M | ||
|
Personalis
PSNL
|
-4.87 | $ 9.39 | 5.03 % | $ 838 M | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.54 | -1.54 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 6.32 | -1.71 % | $ 264 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 65.58 | 1.09 % | $ 3.92 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 259.14 | 0.28 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 451.64 | 0.76 % | $ 170 B | ||
|
Waters Corporation
WAT
|
60.2 | $ 342.31 | 1.07 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.67 | 3.45 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.29 | 1.64 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 194.75 | 0.97 % | $ 21.6 B |